If you are interested, call us to complete some screening paperwork we can deliver to you digitally
Long-term success depends on consistent medication use and maintaining healthy lifestyle habits
September 18, 2025: Still Awaiting New Jersey Decision on Vision Loss Lawsuits We are still awaiting word from the New Jersey Supreme Court on whether or not Ozempic vision loss lawsuits will be grouped together into an MCL
This new indication, based on the SOUL data, marks even further advancement and showcases the versatility of semaglutide while expanding options for millions of people. As the only FDA-approved GLP-1 therapy in a pill, now recognized for its proven cardiovascular benefits, a new benchmark has been set for future oral innovations, added Dave Moore, executive vice president of US Operations for Novo Nordisk
Medical records from hospital visits for issues like vomiting, stomach problems or blood clots